The fine-tune regulation of NR4A receptors in monocytic lineage cells and their relevant role in metabolism [107], have led to propose NOR-1, together with PPARδ, another NR which modulates macrophage function and inflammation [132], as biomarkers of metabolic syndrome [133]. This evidence concerns the gene NR4A3 and metabolic syndrome.